Follow the OptiBiotix Health Plc stock price and the full directors' dealings record of the company, a listed equity based in United Kingdom. Shares trade on the UK market, under the authority of RNS (LSE). Market capitalisation: €5.8m. The latest transaction was disclosed on 1 June 2026 (Purchase). Among the most active insiders: David Blain. All data is accessible without an account.
5
Insider Decl.
n/a
Thresholds
€45,304
5 ops.
Buy Volume
n/a
n/a
Sell Volume
27Σ signal
Buys €45,304n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,131 of 29,063 companies
22.0
score / 100
Value
5
Quality
39
FCF yld-30%
Earn yld-67%
EV/EBITDA·
ROE-53%
Gross mgn53%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 shares@ £0.097849.5% of flowLondonISINISIN GB00BP0RTP38RNS:5834169-0
5 of 5 declarations
Acerca de OptiBiotix Health Plc
OptiBiotix Health Plc es una empresa con sede en el Reino Unido centrada en el desarrollo de productos sanitarios basados en probióticos y prebióticos. Su objetivo es mejorar la salud humana y el control del peso.